EPIFOAM is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Meda Pharmaceuticals. The primary component is Pramoxine Hydrochloride; Hydrocortisone Acetate.
Product ID | 0037-6824_74d3a7b5-1602-4861-a662-50fe63a9cdfe |
NDC | 0037-6824 |
Product Type | Human Prescription Drug |
Proprietary Name | EPIFOAM |
Generic Name | Pramoxine Hydrochloride And Hydrocortisone Acetate |
Dosage Form | Aerosol, Foam |
Route of Administration | TOPICAL |
Marketing Start Date | 2014-08-25 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA086457 |
Labeler Name | Meda Pharmaceuticals |
Substance Name | PRAMOXINE HYDROCHLORIDE; HYDROCORTISONE ACETATE |
Active Ingredient Strength | 100 mg/10g; mg/10g |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2014-08-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA086457 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2014-08-25 |
Ingredient | Strength |
---|---|
PRAMOXINE HYDROCHLORIDE | 100 mg/10g |
SPL SET ID: | b22b8b41-2f1e-11e4-8c21-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0037-6824 | EPIFOAM | pramoxine hydrochloride and hydrocortisone acetate |
75834-197 | HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE | PRAMOXINE HYDROCHLORIDE and HYDROCORTISONE ACETATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EPIFOAM 85707236 4317089 Live/Registered |
Alaven Pharmaceutical LLC 2012-08-18 |
EPIFOAM 85087478 4169927 Live/Registered |
BIODERMIS CORPORATION 2010-07-19 |
EPIFOAM 76411916 2771043 Dead/Cancelled |
NV BIOMEDICAL, INC. 2002-05-24 |
EPIFOAM 73225995 1168878 Dead/Cancelled |
Block Drug Company, Inc. 1979-08-03 |